Company
Headquarters: Hangzhou, China
Employees: 487
CEO: Dr. Zhong Zhao
Company | Market Cap (USD) |
---|---|
Abbott | $213.72 B |
Stryker | $150.01 B |
Boston Scientific Corporation | $149.80 B |
Medtronic | $114.44 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices China. It primarily offers Thrombite Clot Retriever Device, a minimally invasive device to capture and remove the clot blocking blood vessels to treat neurovascular diseases such as acute ischemic stroke; and Ultrafree Drug Coated PTA Balloon Catheter, an interventional device for percutaneous transluminal angioplasty for patients with stenosis or occlusion in femoral artery and popliteal artery. The company also provides neurovascular embolization coils used in the endovascular coiling procedure; flow diverters for endovascular treatment of intracranial aneurysms; retrievable inferior vena cava filters that are placed into the inferior vena cava to prevent pulmonary embolism; peripheral venous stent system for the treatment of iliac vein stenosis or occlusive disease; and suture-mediated closure system used to suture the femoral artery access site after diagnostic/therapeutic interventional procedures. Zylox-Tonbridge Medical Technology Co., Ltd. was founded in 2012 and is headquartered in Zhejiang, the People's Republic of China.
Zylox-Tonbridge Medical Technology Co. Ltd has the following listings and related stock indices.
Stock: HKEX: 2190 wb_incandescent
Stock: FSX: 818 wb_incandescent
Stock: Munich: 818 wb_incandescent